Cleveland Biolabs enters private placement agreement with strategic investor for $25M; Thermo Fisher opens manufacturing site in Scotland;

> Cleveland BioLabs ($CBLI) has entered into a private placement agreement with David Davidoich for $25 million in equity financing. Release

> Thermo Fisher ($TMO) opened a media manufacturing site in Scotland, which will manufacture products used for vaccines and biotherapeutics. Report

> Merck ($MRK) cut contractor jobs at its vaccine plant in Durham, NC. No full-time Merck employees were affected, the company said. More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.